ICBA Leadership

Dr. Wallace Chih-Hwa Lin is the Secretary-General of Taiwan BIO. He has more than 30 years of experience in management, regulatory, and government policy of science and technology. He has been the Chief Administrative Officer of BioMed Taiwan following his tenure as the Director of Biotechnology, Health, Medicine, and Agriculture in the Board of Science and Technology Executive Yuan of Taiwan (BOST) of Taiwan. Wallace was the Acting Deputy Executive Director of the Center for Drug Evaluation (CDE), the regulatory agency for the review of Pharmaceuticals, Medical Devices, Health Food, and Health Technology Assessment in Taiwan. He has been one of the full-time Science and Technology Advisors of the Ministry of Economic Affairs. Wallace is the founder and CEO of SynNovate, a technology-based firm established in Taiwan and with a presence in Asia.

He was Director of the Specialty Polymers Lab in Union Chemical Laboratories, ITRI, and an Adjunct Associated Professor of Biotechnology in National Chaio-Tung University and Chung-Yuan Christian University.

Jessica Martinsson is CEO and Director General of SwedenBIO, where she works to strengthen Sweden's position as a leading life science nation. A chemist by training and entrepreneur by experience, she has spent more than three decades translating science into innovation—from medicinal chemistry and drug discovery to company building and industry leadership.

As co-founder of Sprint Bioscience, Jessica helped grow a pioneering drug discovery company, drawing on earlier experience from Pharmacia and Biovitrum. Today, she is a leading voice for Sweden's life science sector, promoting collaboration, innovation-friendly policy, and international competitiveness to accelerate the development of new medicines and health technologies that benefit patients and society.

Kathleen Stevens serves as Senior Director, National Security at the Biotechnology Innovation Organization (BIO), where she works to advance policies that support enabling U.S. and global ecosystems for biotechnology innovation, growth, and commercialization.

Prior to joining BIO, Kathleen held senior roles at the U.S. Department of State, shaping policy in international science and technology cooperation, global health and biodefense, and biotechnology. A trained immunologist and epidemiologist with scientific experience in industry and academia, Kathleen holds a Ph.D. in Microbiology and Immunology from Johns Hopkins, an M.S. in Epidemiology from Temple University, and a B.S. in Biology from Carnegie Mellon University.